4.7 Article

A Variant in the KCNQ1 Gene Predicts Future Type 2 Diabetes and Mediates Impaired Insulin Secretion

期刊

DIABETES
卷 58, 期 10, 页码 2409-2413

出版社

AMER DIABETES ASSOC
DOI: 10.2337/db09-0246

关键词

-

资金

  1. Swedish Research Council [31475113580]
  2. Heart and Lung Foundation
  3. Swedish Diabetes Research Society
  4. European Community [FP7/2007-2013]
  5. ENGAGE
  6. Nordic Centre of Excellence Grant in Disease Genetics
  7. Diabetes Programme at Lund University
  8. Pahlsson Foundation
  9. Crafoord Foundation
  10. Knut and Alice Wallenberg Foundation
  11. European Foundation for the Study of Diabetes (EFSD)
  12. Finnish Diabetes Research Society
  13. Sigrid Juselius Foundation
  14. Folkhalsan Research Foundation
  15. Signe and Ane Gyllenberg Foundation
  16. Swedish Cultural Foundation in Finland
  17. Ollqvist Foundation
  18. Foundation for Life and Health in Finland
  19. Jakobstad Hospital
  20. Medical Society of Finland,
  21. Narpes Research Foundation
  22. Vasa and Narpes Health Centers
  23. [HEALTH-F4-2007-201413]

向作者/读者索取更多资源

OBJECTIVE-Two independent genome-wide association studies for type 2 diabetes in Japanese subjects have recently identified common variants in the KCNQ1 gene that are strongly associated with type 2 diabetes. Here we studied whether a common variant in KCNQ1 would influence BMI as well as insulin secretion and action and predict future type 2 diabetes in subjects from Sweden and Finland. RESEARCH DESIGN AND METHODS-Risk of type 2 diabetes conferred by KCNQ1 rs2237895 was studied in 2,830 type 2 diabetic case subjects and 3,550 control subjects from Sweden (Malmo Case-Control) and prospectively in 16,061 individuals from the Malmo Preventive Project (MPP). Association between genotype and insulin secretion/action was assessed cross-sectionally in 3,298 nondiabetic subjects from the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia Study and longitudinally in 2,328 nondiabetic subjects from the Botnia Prospective Study (BPS). KCNQ1 expression (n = 18) and glucose-stimulated insulin secretion (n = 19) were measured in human islets from nondiabetic cadaver donors. RESULTS-The C-allele of KCNQ1 rs2237895 was associated with increased risk of type 2 diabetes in both the Malmo Case-Control (odds ratio 1.23 [95% CI 1.12-1.34]; P = 5.6 X 10(-6)) and the prospective (1.14 [1.06-1.22]; P = 4.8 X 10(-4)) studies. Furthermore, the C-allele was associated with decreased insulin secretion (corrected insulin response [CIR] P = 0.013; disposition index [DI] P = 0.013) in the PPP-Botnia Study and in the BPS at baseline (CIR P = 3.6 X 10(-4); DI P = 0.0058) and after follow-up (CIR P = 0.0018; DI P = 0.0030). C-allele carriers showed reduced glucose-stimulated insulin secretion in human islets (P = 2.5 X 10(-6)). CONCLUSIONS-A common variant in the KCNQ1 gene is associated with increased risk of future type 2 diabetes in Scandinavians, which partially can be explained by an effect on insulin secretion. Diabetes 58:2409-2413, 2009

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据